MiNK Therapeutics, Inc. (INKT)

NASDAQ: INKT · Real-Time Price · USD

11.47

+0.24 (2.14%)

Feb 24, 2026, 4:00 PM EST - Market closed

MiNK Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	54	28	37	88	149	-
Market Cap Growth	21.41%	-25.23%	-58.11%	-40.99%	-	-
Enterprise Value	45	26	31	64	214	-
Last Close Price	11.47	6.97	10.70	26.10	44.60	-
PB Ratio	-	-1.41	-2.05	-219.74	6.29	-
P/TBV Ratio	-	-	-	-	6.29	-
Debt / Equity Ratio	-0.42	-0.25	-	-	-	-0.81
Net Debt / Equity Ratio	0.63	-0.02	0.19	48.93	-1.64	-0.76
Net Debt / EBITDA Ratio	0.70	-0.03	0.15	0.64	2.10	-3.83
Net Debt / FCF Ratio	1.53	-0.04	0.21	1.03	2.97	-4.88
Quick Ratio	1.06	0.66	0.30	1.55	2.36	0.21
Current Ratio	1.08	0.72	0.32	1.61	2.41	0.29
Return on Equity (ROE)	-	-	-	-239.50%	-	-
Return on Assets (ROA)	-69.61%	-137.35%	-110.10%	-62.69%	-51.92%	-230.14%
Return on Capital Employed (ROCE)	-813.00%	911.20%	334.60%	-352.20%	-78.30%	111.70%
Earnings Yield	-22.95%	-39.05%	-60.80%	-31.74%	-20.22%	-
FCF Yield	-10.36%	-34.60%	-42.87%	-21.68%	-8.75%	-
Buyback Yield / Dilution	-12.09%	-9.82%	-2.04%	-29.38%	-7.95%	-0.21%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q